Trials / Completed
CompletedNCT02956278
The Effects of BCRP Q141K on Allopurinol Pharmacokinetics and Dynamics
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 27 (actual)
- Sponsor
- University of California, San Francisco · Academic / Other
- Sex
- All
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Subjects will undergo a placebo and allopurinol phase to better understand the effects of the reduced function BCRP Q141K variant on allopurinol pharmacokinetics and pharmacodynamics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Allopurinol | |
| OTHER | Placebo | lactose placebo pill |
Timeline
- Start date
- 2016-11-01
- Primary completion
- 2018-03-01
- Completion
- 2018-03-01
- First posted
- 2016-11-07
- Last updated
- 2020-06-23
- Results posted
- 2020-06-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02956278. Inclusion in this directory is not an endorsement.